Matches in Nanopublications for { ?s ?p "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP310246.RAShluCAKFZVgbX3vRRaHZ4JriyDPTdAtAGZqh4An3W3I130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310246.RAShluCAKFZVgbX3vRRaHZ4JriyDPTdAtAGZqh4An3W3I130_provenance.
- NP910028.RADfSNLKZjGakvQEoan59vVezb_xehYA3xeqcFxybHoj4130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910028.RADfSNLKZjGakvQEoan59vVezb_xehYA3xeqcFxybHoj4130_provenance.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_provenance.
- NP310268.RAqgOONQzsuiL2I-9LfVkL8hwUtXHnHOpVtpONydQwp3s130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310268.RAqgOONQzsuiL2I-9LfVkL8hwUtXHnHOpVtpONydQwp3s130_provenance.
- NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- NP910018.RARxwapMLbvKGUQaSrbtQ6XCAfAisSKA0-zw9tPWPZiBw130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910018.RARxwapMLbvKGUQaSrbtQ6XCAfAisSKA0-zw9tPWPZiBw130_provenance.
- NP1295106.RApo-bbM0fsQ53g2hmNKuA23wDg2W0wPDl15jgGjuFt6I130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295106.RApo-bbM0fsQ53g2hmNKuA23wDg2W0wPDl15jgGjuFt6I130_provenance.
- NP910027.RAv_pp-LEZfRZgL1ApUnhn8cFNmHnE0hKejmjl9x7Qfl8130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910027.RAv_pp-LEZfRZgL1ApUnhn8cFNmHnE0hKejmjl9x7Qfl8130_provenance.
- NP910023.RAwj73dl8KBZD0SSYJZGOYVo1ddSuVzawrm_SjQcNZl8w130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910023.RAwj73dl8KBZD0SSYJZGOYVo1ddSuVzawrm_SjQcNZl8w130_provenance.